|

Genetic Counseling for Mesothelioma: What You Need to Know

ByHolly Zink
Genetic Counseling for Mesothelioma: What You Need to Know

People with a family history of thoracic cancers like mesothelioma should think about getting genetic counseling.

This is the recommendation of researchers from the United States and the United Kingdom. They explored what we know about how changes in a person’s genes passed down through their family can increase their chances of developing cancer.

The Power of Genetic Knowledge

Mesothelioma is a type of cancer that is caused by exposure to asbestos. It most often occurs in the lungs or in the abdominal cavity. With the best conventional treatments, people with this cancer typically have a median survival of a little over a year for mesothelioma in the lungs and about five years for mesothelioma in the abdomen.

There is a growing amount of research that shows that people with certain genes can be more likely to develop mesothelioma after asbestos exposure than others. These changes are called pathogenic germline variants (PGVs).

A mutation in a gene called BAP1 is linked with mesothelioma growth. People with this mutation may develop mesothelioma faster after being exposed to asbestos.

It is not currently standard practice to routinely test for PGVs in thoracic cancers like mesothelioma. But it may be important for people who have a family history of these cancers or other risk factors to receive genetic counseling from experts.

Mesothelioma and Family History

One obstacle to this practice is legal disputes. Many patients with mesothelioma are involved in lawsuits about their diagnosis due to exposure to asbestos. They are often worried that if a PGV is identified in their genes, it can be used against them in court as the cause of their cancer instead of asbestos exposure.

It is the responsibility of genetic counselor to discuss this concern with patients so they can make the best decision for themselves and their unique situation. This includes explaining the Genetic Information Non-Discrimination Act, a law that protects people in the United States from discrimination based on their genetic information.

Knowledge of their genetic makeup and PGVs like BAP1 can help patients and doctors in preventing cancer and improving cancer treatment to enhance patients’ quality and length of life.

Source

Hathaway F, Martins R, Sorscher S, Bzura A, Dudbridge F, Fennell DA. Family Matters: Germline Testing in Thoracic Cancers. Am Soc Clin Oncol Educ Book. 2023;43:e389956. doi:10.1200/EDBK_389956. https://ascopubs.org/doi/10.1200/EDBK_389956

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Mesothelioma Victims’ Victory in Pennsylvania

    ByAlex Strauss

    Workers and their families have won a victory in Pennsylvania after the state Supreme Court ruled that they could sue former employers over late-manifesting industrial diseases like mesothelioma. The decision focused on a provision in Pennsylvania’s Workers’ Compensation Act that says workers cannot sue an employer if their occupational disease occurred more than 300 weeks after their on-the-job exposure. While many occupational injuries and diseases occur within weeks or months of exposure to a toxin, asbestos diseases like mesothelioma are a notable exception. Believed to be caused by chronic irritation from inhaled or ingested asbestos fibers, mesothelioma does not usually begin to cause symptoms until at least a decade after exposure. Expressing the opinion of the majority, Supreme Court Justice…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    ByAlex Strauss

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • |

    Mesothelioma Blood Test May Be Possible

    ByAlex Strauss

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • |

    Mesothelioma Still Carries Heavy Mortality Burden in U.S.

    ByAlex Strauss

    Asbestos exposure cost Americans more than 427,000 years of potential life in the first decade of the new millennium. That figure comes from a study on mesothelioma and asbestosis – the two most deadly asbestos-related diseases – conducted by the CDC’s National Institute for Occupational Safety and Health (NIOSH). Using National Center for Health Statistics mortality data, NIOSH researchers evaluated premature deaths and “loss of potentially productive years of life” attributable to either asbestosis or mesothelioma between 1999 and 2010. The data included only people 25 years or older with an underlying cause of death listed on their death certificate of either asbestosis or malignant mesothelioma. When the figures were calculated using the normal life expectancy for each asbestosis victim…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    ByAlex Strauss

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…